<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0268390" disease_type="Disease or Syndrome" abbrv="">Muckle-Wells syndrome</z:e> (MWS) is a subset of autoinflammatory diseases </plain></SENT>
<SENT sid="1" pm="."><plain>It is characterized by recurrent inflammatory crises associated with <z:hpo ids='HP_0001945'>fever</z:hpo>, <z:hpo ids='HP_0002027'>abdominal pain</z:hpo>, persistent <z:hpo ids='HP_0001025'>urticaria</z:hpo>, <z:hpo ids='HP_0002829'>arthralgia</z:hpo>, <z:hpo ids='HP_0000407'>sensorineural deafness</z:hpo>, and possible development of multiorgan amyloid A protein (AA)-type <z:hpo ids='HP_0011034'>amyloidosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Mutations in the CIAS1 gene have been reported in MWS </plain></SENT>
<SENT sid="3" pm="."><plain>Interleukin 1B (IL-1B) probably plays a major role in the pathophysiology of the disease, and IL-1B blockade may be therapeutic for this syndrome </plain></SENT>
<SENT sid="4" pm="."><plain>We report here a Turkish child with MWS treated with anakinra </plain></SENT>
<SENT sid="5" pm="."><plain>A novel mutation (I480F) was identified in exon 3 of the CIAS1 gene in this patient </plain></SENT>
<SENT sid="6" pm="."><plain>The resolution of inflammatory symptoms, normalization of serological values, and improvement in hearing was noted with anakinra treatment </plain></SENT>
</text></document>